NCT00237250
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Intolerance, +5 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Explore clinical trials studying Hyperglycemia. Study availability and eligibility vary by location and protocol.
NCT00237250
NCT00241072
Not specified
NCT00992641
NCT00573781
NCT01574820
Not specified
NCT00870077
NCT00652379
NCT01456754
NCT00364377
NCT01346254